The NASDAQ Biotech ETF is trading back to the important 285 level. This level was support last September and resistance in April and June. It was support through August but it was broken yesterday. If this level doesn't hold I would expect a tradable move to the downside over the next few weeks.
Here is a shorter-term view since March.